|
|
|
General Conditions Reference
|
The Role of Detoxification in the Prevention of Chronic Degenerative Diseases: A Summary |
 |
|
The Role of Detoxification in the Prevention of
Chronic Degenerative Diseases: A Summary
By DeAnn J. Liska, Ph.D. and Robert
Rountree, M.D.
Low-level, long-term exposure to toxins such as heavy
metals (e.g. lead, mercury, arsenic, cadmium),
pesticides, industrial compounds, and pollutants is
associated with chronic fatigue syndrome (CFS),
multiple chemical sensitivities (MCS), fibromyalgia
(FM), neurodegenerative diseases such as Parkinson?s
and atherosclerosis, and many types of
cancers.1-4 Common signs and symptoms of
environmental toxicity include acne, rashes, headaches,
aches and pains, fatigue, muscle weakness, tinnitus,
fertility problems, memory loss, and chronic immune
system depression.
Toxins can remain in the body for many years; therefore,
we are exposed to much higher toxin doses than present
environmental concentrations suggest. Research suggests
we all maintain toxin contamination within our bodies
on a regular basis due to this lifetime of exposure.
How Does the Body Remove Toxic Substances?
An individual?s ability to remove?or detoxify?toxins is
a primary factor in susceptibility to toxin-related
conditions.5-11 In order to remove (excrete)
the multitude of diverse toxins, the body has a complex
system that converts them into non-toxic molecules for
removal. This complex system occurs in two phases?Phase
I and Phase II?that together convert (biotransform) a
toxic molecule into a non-toxic molecule that can be
easily excreted. The majority of detoxification occurs
in the liver; however, all tissues have some ability to
detoxify, including the intestines, skin, and lungs.
In Phase I, a functional group is added to the toxic
molecule producing an intermediate that needs to be
further transformed. Phase II detoxification involves a
process called conjugation, in which various enzymes in
the liver attach protective compounds to the
intermediate, making it less harmful and more readily
excretable. Because the products of Phase I can be
highly reactive and more harmful than the original
compound, achieving and maintaining a balance between
the Phase I and Phase II processes is critical.
Furthermore, a significant side effect of all this
metabolic activity is the production of free radicals
as the toxins are transformed, resulting in oxidative
stress. Nutrients that help protect from oxidative
stress include vitamins C and E, zinc, selenium, and copper.12,13
Achieving Balanced Detoxification
Optimal detoxification requires that both Phase I and
Phase II pathways function optimally and in balance with
each other. Bifunctional modulators are phytonutrients
that support balanced detoxification by modulating
Phase I and promoting Phase II. This minimizes damage by
reactive intermediates and free radicals. Fruits and
vegetables contain many bifunctional modulators, which
is one reason these foods are associated with reduced
susceptibilities to cancer and degenerative diseases.14
Nutritional Support for Detoxification
Detoxification is an energy-requiring process that puts
a metabolic burden on the body. Therefore, water or
juice fasts are not beneficial because they deplete the
body of the essential nutrients required for healthy
detoxification. These fasts can have many adverse
health effects, including decreased energy production,
breakdown of lean tissue instead of fat, increased
oxidative stress, and unbalanced detoxification.15,16
Instead of decreasing nutrient support, a focused,
high-impact, low-allergy-potential source of
macronutrients should be provided. High-quality protein
provides methionine and cysteine, which are beneficial
to Phase II and may help with toxic metal
burdens.17 Medium chain triglycerides (MCTs)
support energy production,18and olive oil
may protect against chemically-induced liver
damage.19 Fiber supports fecal excretion
of toxins and the integrity of the intestinal barrier,
which decreases toxic burden. In particular, rice bran
can directly bind some toxins, thereby removing them
before they can enter the body and cause damage.20
Nutrients that support energy production include vitamin
B1 (thiamin), vitamin B2 (riboflavin), niacin, vitamin
B5 (pantothenic acid), and magnesium. In addition, the
following nutrients and phytonutrients provide targeted
support for optimal detoxification:
N-Acetylcysteine and Sodium Sulfate promote
generation of glutathione, which is used in Phase II
and is a major route for detoxification of heavy
metals, and supports Phase II sulfation.16,21
Vitamin B12, Folate, Methionine, and Choline
promote balanced detoxification by supporting Phase II
methylation and healthy homocysteine recycling. Choline
deficiency is causative for liver disease, and is a
newly-designated essential nutrient.22-24
The biologically-active, natural form of folate is 5-methyltetrahydrofolate.25
Ellagic Acid from pomegranate significantly
reduces tumors in animals with chemically-induced
cancers, protects from toxin liver damage, enhances
glutathione production, decreases lipid peroxidation,
and binds some metals, thus promoting their
excretion.26-29 It is a bifunctional
modulator that can bind some toxins directly, rendering
them non-toxic, and can directly bind and protect DNA.30,31
Catechins from green tea are bifunctional
modulators that are strong antioxidants possessing
anticarcinogenic and antimutagenic
potential.32,33Catechins are associated with
lower incidence of Parkinson?s
disease.33,34The National Cancer Institute
is currently investigating the chemotherapeutic
potential of green tea catechins.35Catechins
also promote healthy gastrointestinal function.36
Watercress (Nasturtium officinale)
contains high levels of glucosinolates, which are
precursors to several bioactives that can inhibit
chemically-induced cancers in animals, and promote
excretion of carcinogens in humans.37-41 The
bifunctional activity of watercress is one of the
proposed mechanisms for its chemoprotective effect.37,42-44
Silymarin from milk thistle is a well-known
liver-protectant that may improve liver function in
patients with liver disease and
toxicity.45-47 Silymarin increases
glutathione and is a strong antioxidant.46-49
Artichoke (Cynara scolymus) is also a
liver-protectant with a long history of traditional use
that provides strong antioxidant protection and may
decrease the loss of glutathione after toxic exposure.50-53
Summary
Minimizing exposure to toxins is only one part of a
beneficial detoxification program. Low-allergy
potential, targeted nutrition providing the full
spectrum of Phase II supportive cofactors, bifunctional
modulators for balanced detoxification, and support for
energy production and excretion may optimize balanced
detoxification and promote optimal health throughout life.
References
- Bachurin SO, Tkachenki SE, Lermontova NN.
Pyridin derivatives: structure-activity
relationships causing parkinsonism-like
symptoms. Rev Environ Contam Toxicol 1991;122:1-36.
- Buckley JD, Meadows AT, Kadin ME, et al.
Pesticide exposures in children with non-Hodgkin
lymphoma. Cancer
2000;89(11):2315-21.
- Meinert R, Schuz J, Kaletsch U, et al.
Leukemia and non-Hodgkin?s lymphoma in childhood
and exposure to pesticides: results of a
register-based case-control study in Germany.
Am J Epidemiol
2000;151(7):639-46, 647-50.
- Rothman N, Cantor KP, Blair A, et al. A
nested case-control study of non-Hodgkin
lymphoma and serum organochlorine
residues. Lancet 1997;350:240-44.
- Dunstan RH, Donohoe M, Taylor W, et al. A
preliminary investigation of chlorinated
hydrocarbons and chronic fatigue syndrome.
Med J Aust 1995;163(6):294-97.
- Bell IR, Baldwin CM, Schwatz GE. Illness
from low levels of environmental chemicals:
relevance to chronic fatigue syndrome and
fibromyalgia. Am J Med
1998;105(3A):74S-82S.
- Salonen JT, Seppanen K, Lakka TA, et al.
Mercury accumulation and accelerated
progression of carotid atherosclerosis: a
population-based prospective 4-year
follow-up study in men in eastern Finland.
Atherosclerosis 2000;148:265-73.
- Racciatti D, Vecchiet J, Ceccomancini A,
et al. Chronic fatigue syndrome following a
toxic exposure. Sci Total Environ
2001;270(1-3):27-31.
- Wang C-H, Jeng J-S, Yip P-K, et al.
Biological gradient between long-term
arsenic exposure and carotid atherosclerosis.
Circulation 2002;105:1804-09.
- Kirkhorn SR, Schenker MB. Current health
effects of agricultural work: respiratory
disease, cancer, reproductive effects,
musculoskeletal injuries, and pesticide-related
illnesses. J Agric Saf Health 2002;8(2):199-214.
- Liska DJ. The detoxification enzyme
systems. Altern Med Rev 1998;3(3):187-98.
- Aw TY, Jones DP. Nutrient supply and
mitochondrial function. Annu Rec Nutr 1989;9:229-51.
- Bland JS, Bralley JA. Nutritional
upregulation of hepatic detoxification enzymes.
J Appl Nutr 1992;44:2-15.
- Nestle M. Broccoli sprouts in cancer
prevention. Nutr Rev 1998;56(4 Pt 1):127-30.
- Lall SB, Singh B, Gulati K, et al. Role of
nutrition in toxic injury. Indian J Exp
Biol 1999;37(2):109-16.
- Bland JS, Barrager E, Reedy G, et al. A
medical food-supplemented detoxification
program in the management of chronic health
problems. Altern Ther Health Med 1995;1(5):62-71.
- Quig D. Cysteine metabolism and metal
toxicity. Altern Med Rev 1998;3(4):262-70.
- DeGaetano A, Castagneto M, Mingrone G, et
al. Kinetics of the medium-chain triglycerides
and free fatty acids in healthy volunteers
and surgically stressed patients. J
Parenteral Enteral Nutr
1994;18:134-40.
- McDanell RE, Henderson LA, Russell K, et
al. The effect of Brassica vegetable consumption
on caffeine metabolism in humans. Human
Exp Toxicol 1992;11:167-72.
- Harris PJ, Sasidharan VK, Roberton AM, et
al. Adsorption of a hydrophobic mutagen to
cereal brans and cereal bran dietary
fibres. Mutation Res 1998;412:323-31.
- Olmstead MJ. Heavy metal sources, effects,
and detoxification. Altern Ther Complement
Med 2000;Dec;347-54.
- Buchman AL, Ament ME, Sohel M, et al.
Choline deficiency causes reversible hepatic
abnormalities in patients receiving
parenteral nutrition: Proof of a human choline
requirement: A placebo-controlled trial.
J Parenteral Enteral Nutr 2001;25:260-68.
- Zeisel SH. Choline: an essential nutrient
for humans. Nutrition 2000;16:669-71.
- Miller DL. Health benefits of lecithin and
choline. Cereal Foods World 2002;47:178-84.
- Scott J. Methyltetrahydrofolate: the
superior alternative to folic acid. In: Krhamer
K, Hoppel P-P, eds. Nutraceuticals in
Health and Disease Prevention. New York:
Marvel Dekker, 2001;6:75-90.
- Khanduja KL, Gandhi RK, Pathania V, et al.
Prevention of N-nitrosodiethylamine-induced lung
tumorigenesis by ellagic acid and
quercetin in mice. Food Chem Toxicol 1999;37(4):313-18.
- Anderson KE, Kappas A. Dietary
regulation of cytochrome P450. Annu Rev
Nutr 1991;11:141-67.
- Ahn D, Putt D, Kresty L, et al. The
effects of dietary ellagic acid on rat hepatic
and esophageal mucosal cytochromes P450
and phase II enzymes. Carcinogenesis 1996;17(4):821-28.
- Ahmed S, Rahman A, Saleem M, et al.
Ellagic acid ameliorates nickel induced
biochemical alterations: diminution of
oxidative stress. Human Exp Toxicol 1999;18:691-98.
- Barch DH, Rundhaugen LM, Stoner GD, et al.
Structure-function relationships of the dietary
anticarcinogen ellagic acid.
Carcinogenesis 1996;17(2):265-69.
- Barch DH, Rundhaugen LM, Pillay NS.
Ellagic acid induces transcription of the rat
glutathione S-transferase-Ya gene.
Carcinogenesis 1995;16(3):665-68.
- Ahmad N, Muktar H. Green tea polyphenols
and cancer: biological mechanisms and practical
implications. Nutr Rev 1999;57(3):78-83.
- McKay DL, Blumberg JB. The role of tea in
human health: an update. J Am Coll Nutr 2002;21(1):1-13.
- Ross GW, Abbott RD, Petrovitch H, et al.
Association of coffee and caffeine intake with
the risk of Parkinson disease. JAMA 2000;283:2674-79.
- Steele VE, Kelloff GJ, Balentine D, et al.
Comparative chemopreventive mechanisms of green
tea, black tea, and selected polyphenol
extracts measured by in vitro bioassays.
Carcinogenesis 2000;21(1):63-67.
- Goto K, Kanaya S, Ishigami T, et al. The
effects of tea catechins on fecal conditions of
elderly residents in a long-term care
facility. J Nutr Sci Vitaminol 1999;45:135-41.
- Getahun SM, Chung F-L. Conversion of
glucosinolates to isothiocyanates in humans
after ingestion of cooked watercress.
Cancer Epidemiol Biomarkers Prev 1999;8:447-51.
- Krul C, Humblot C, Phillippe C, et al.
Metabolism of sinigrin (2-propenyl
glucosinolate) by the human colonic
microflora in a dynamic in vitro large-intestine
model. Carcinogenesis 2002;23:1009-16.
- Hecht SS. Chemoprevention of cancer by
isothiocyanates, modifiers of carcinogen
metabolism. J Nutr 1999;129:768S-74S.
- Chung FL, Conaway CC, Rao CV, et al.
Chemoprevention of colonic aberrant crypt foci
in Fischer rats by sulforaphane and
phenethyl isothiocyanate. Carcinogenesis 2000;21(12):2287-91.
- Hecht SS, Carmella SG, Murphy SE. Effects
of watercress consumption on urinary metabolites
of nicotine in smokers. Cancer
Epidemiol Biomarkers Prev 1999;8:907-13.
- Rose P, Faulkner K, Williamson G, et al.
7-Methylsulfinylheptyl and 8-methylsulfinyloctyl
isothiocyanates from watercress are potent
inducers of phase II enzymes.
Carcinogenesis 2000;21(11):1983-88.
- Leclercq I, Desager JP, Horsmans Y.
Inhibition of chlorzoxazone metabolism, a
clinical probe for CYP2E1, by a single
ingestion of watercress. Clin Pharmacol
Ther 1998;64(2):144-49.
- Hecht SS, Chung F-L, Richie JP Jr, et al.
Effects of watercress consumption on metabolism
of a tobacco-specific lung carcinogen in
smokers. Cancer Epidemiol Biomarkers
Prev 1995;4:877-84.
- Saller R, Meier R, Brignoli R. The use of
silymarin in the treatment of liver diseases.
Drugs 2001;61(14):2035-63.
- Wellington K, Jarvis B. Silymarin: a
review of its clinical properties in the
management of hepatic disorders.
BioDrugs 2001;15(7):465-89.
- DeLeve LD, Kaplowitz N. Glutathione
metabolism and its role in hepatotoxicity.
Pharmacol Ther 1991;52(3):287-305.
- Yanaida Y, Kohno H, Yoshida K, et al.
Dietary silymarin suppresses 4-nitroquinoline
1-oxide-induced tongue carcinogenesis in
male F344 rats. Carcinogenesis 2002;23(5):787-94.
- Kosina P, Kren V, Gebhardt R, et al.
Antioxidant properties of silybin glycosides.
Phytotherapy Res 2002;16:S33-S39.
- Perez-Garcia F, Adzet T, Canigueral S.
Activity of artichoke leaf extract on reactive
oxygen species in human leukocytes.
Free Rad Res 2000;33:661-65.
- Llorach R, Espin JC, Thomas-Barberan FA,
et al. Artichoke (Cynara scolymus
L.) byproducts as a potential
source of health-romoting antioxidant phenolics.
J Agric Food Chem 2002;50:3458-64.
- Rechner AR, Pannala AS, Rice-Evans CA.
Caffeic acid derivatives in artichoke extract
are metabolised to phenolic acids in
vivo. Free Rad Res 2001;35:195-202.
- Gebhardt R. Antioxidant and protective
properties of extracts from leaves of the
artichoke (Cynara scolymus L.)
against hydroperoxide-induced oxidative stress
in cultured rat hepatocytes. Toxicol
Appl Pharmacol 1997;144:279-86.
Advanced Nutrition Publications ©2002
More Articles:
Chronic stuffy nose tied to high blood pressure
Machine washing removes most dust mites
Diet may influence hay fever risk
Gut Dysfunction and Chronic Disease: The Benefits of Applying the 4R GI Restoration Program
Th1/Th2 Balance: A Natural Therapeutic Approach To Th2 Polarization In Allergy
Effects of Boswellia serrata in asthma patients: results of a 6-week study
The anti-inflammatory actions of curcumin and boswellia
The Role of Detoxification in the Prevention of Chronic Degenerative Diseases: A Summary
The detoxification enzyme systems
Role of nutrition in preventing toxic injury
Nutritional support of liver detoxification enzymes
Dietary regulation of liver detoxification
A medical food-supplemented detoxification program in the management of chronic health problems
Ginger may help prevent allergic reactions
Lactobacillus shown to inhibit allergic response
Omega-3 fatty acid supplementation may reduce asthma symptoms
Perilla extract may help prevent allergic reactions
Perilla seed extract improves allergy symptoms
Defatted perilla seed extract inhibits inflammatory responses
Extract of perilla inhibits allergic reaction
Perilla extract shown to inhibit allergic response
Herbal therapy for the treatment of asthma
Copyright 1998-2001, Reuters Limited.
Reuters content is the intellectual property of Reuters Limited. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. Reuters, the Reuters Dotted Logo and the Sphere Logo are registered trademarks of the Reuters group of companies around the world.
|
|